Panic disorder. A long-term treatment study: Fluoxetine vs imipramine

Human Psychopharmacology

Volumn 14, Issue 6, 1999, Pages 429-434

  Amore, Mario ^a   Magnani, Katia ^a   Cerisoli, Marziano ^a   Casagrande, Carlo ^a   Ferrari, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Fluoxetine; Imipramine; Long term treatment; Panic disorder

Indexed keywords

FLUOXETINE; IMIPRAMINE;

ADULT; AGED; AGITATION; AGORAPHOBIA; ANTICHOLINERGIC EFFECT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INSOMNIA; MALE; NAUSEA; PANIC; PHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SIDE EFFECT; SWEATING; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0032879708     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199908)14:6<429::AID-HUP108>3.0.CO;2-3     Document Type: Article

References (29)

1. Argyle, N., Deltito, J., Allerup, P., Maier, W., Albus, M., Nutzinger, D., Rasmussen, S., Ayuso, J. L. and Bech, P. (1991). The Panic-Associated Symptom Scale: measuring the severity of panic disorder. Acta Psychiatrica Scandinavica, 83, 20-26.
2. Bakish, D., Saxena, B. M. and Bowen, R. and D'Souza, J. (1993). Reversible monoamine oxidase-A inhibitors in panic disorder. Clinical Neuropharmacology, 16(suppl. 2), 77-82.
3. Bakish, D., Hooper, C. L., Filteau, M. J., Charbonneau, Y., Fraser, G., West, D. L., Thibaudeau, C. and Raine, D. (1996). Anxiety and related disorders. Psychopharmacology Bulletin, 32(1), 135-141.
4. Bystritsky, A., Rosen, R. M., Murphy, K. J., Bohn, P., Keys, S. A. and Vapnik, T. (1995). Double-blind pilot trial of desipramine versus fluoxetine in panic patients. Anxiety, 1, 287-290.
5. Davidson, J. R. T. (1998). The long-term treatment of panic disorder. Journal of Clinical Psychiatry, 59(suppl. 8), 17-21.
6. Den Boer, J. A., Westenberg, H. G. M., Kamerbeek, W. D. J., Verhoeven, W. M. A. and Kahn, R. S. (1987). Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. International Clinical Psychopharmacology, 2, 21-32.
7. Faravelli, C. and Albanese, G. (1987). Agoraphobia with panic attacks: 1-year prospective follow-up. Comprehensive Psychiatry, 28, 481-487.
8. Gorman, J. M., Liebowitz, M. R., Fyer, A. J., Goetz, D., Campeas, R. B., Fyer, M. R., Davies, S. O. and Klein, D. F. (1987). An open trial of fluoxetine in the treatment of panic attacks. Journal of Clinical Psychopharmacology, 7, 329-332.
9. Hoehn-Saric, R., McCleod, D. R. and Hipsley, P. A. (1993). Effect of fluvoxamine on panic disorder. Journal of Clinical Psychopharmacology, 13, 321-326.
10. Jefferson, J. W. (1997). Antidepressants in panic disorder. Journal of Clinical Psychiatry, 58(suppl. 2), 20-24.
11. Katschnig, H., Amering, M. A., Stolk, J. M., Klerman, G. L., Ballenger, J. C., Briggs, A., Buller, R., Cassano, G., Garvey, M., Roth, M. and Solyom, C., (1995). Long-term follow-up after a drug trial for panic disorder. British Journal of Psychiatry, 167, 487-494.
12. Keller, M. B., Yonkers, K. A., Warshaw, M. G., Pratt, L. A., Gollan, J. K., Massion, A. O., White, K., Swartz, A. R., Reich, J. and Lavori, P. W. (1994). Remission and relapse in subjects with panic disorder and panic with agoraphobia. Journal of Nervous and Mental Disease, 182(5), 290-296.
13. Lecrubier, Y., Judge, R. and the Collaborative Paroxetine Panic Study Investigators (1997). Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Acta Psychiatrica Scandinavica, 95, 153-160.
14. Lepola, U., Wade, A. G., Leinonen, E. V., Koponen, H. J., Frazer, J., Sjodin, I., Penttinen, J. T., Pedersen, T. and Lehto, H. J. (1998). A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder. Journal of Clinical Psychiatry, 59, 528-534.
15. Louie, A. K., Lewis, T. B. and Lannon, R. A. (1993). Use of low-dose fluoxetine in major depression and panic disorder. Journal of Clinical Psychiatry, 54, 435-438.
16. Norusis, M. J. (1994). SPSS/PC + Advanced Statistics, Version 6.0. SPSS Inc., Chicago.
17. Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K. and Maniiche, P. M. (1995). Paroxetine in the treatment of panic disorder. British Journal of Psychiatry, 167, 374-379.
18. Rickels, K., Schweizer, E., Weiss, S. et al. (1993). Maintenance drug treatment for panic disorder, II: short- and long-term outcome after drug taper. Archives of General Psychiatry, 50, 61-68.
19. Rosenberg, R., Bech, P., Mellergard, M. and Ottosson, J. O. (1991). Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response. Acta Psychiatrica Scandinavica, Suppl. 365, 46-52.
20. SAS (1990). SAS User's Guide; Statistics. Version 6.04. SAS Institute Inc., Cary, NC.
21. Salzman, C. (1993). Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. Journal of Psychiatric Research, 27(suppl. 1), 97-110.
22. Schneier, F., Liebowitz, M. R., Davies, S. O., Faierbanks, J., Hollander, E., Campeas, R. and Klein, D. F. (1990). Fluoxetine in panic disorder. Journal of Clinical Psychopharmacology, 10, 119-121.
23. Sheehan, D. V. and Dunbar, G. (on behalf of the Panic Disorder Study Group) (1996). The treatment of panic disorder with paroxetine. In Proceedings of the Second Novo Nordisk Symposium on Panic Disorder and OCD, Gotesyam, K. G., Mindus, P. and Sheehan, D. V. (Eds), Medical Forum International, Copenhagen, pp. 29-38.
24. Sheehan, D. V. and Harnett-Sheehan, K. (1996). The role of SSRIs in panic disorder. Journal of Clinical Psychiatry, 57(suppl. 10), 51-58.
25. Solyom, L., Solyom, C. and Ledwidge, B. (1991). Fluoxetine in panic disorder. Canadian Journal of Psychiatry, 36, 378-380.
26. Stanton Glantz, A. (1987). Primer of Biostatistics. McGraw Hill, New York.
27. Steiner, M., Oakes, R., Gergel, I. P., Burnham, D. B. and Wheadon, D. E. (1995). A fixed dose study of paroxetine and placebo in the treatment of panic disorder. New Research Program and Abstracts of the 148th Annual Meeting of the American Psychiatric Association, Abstract NR355, 150, Miami, FL.
28. Westenberg, H. G. M. (1997). Panic disorder - a condition for life? Treatment issues. Human Psychopharmacology, 12(suppl. 1), 13-17.
29. Woods, S., Black, D., Brown, S., Asnis, G., Potkin, S., Hameedi, F. and Goddard, A. (1994). Fluvoxamine in the treatment of panic disorder in outpatients: a double-blind, placebo-controlled study. Neuropsychopharmacology, 10(suppl. 3), 103.